{"count": 1, "results": [{"_id": "33681737", "pmid": 33681737, "pmcid": "PMC7910694", "title": "The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial", "journal": "EClinicalMedicine", "authors": ["Amin S", "Mallick AA", "Edwards H", "Cortina-Borja M", "Laugharne M", "Likeman M", "O'Callaghan FJK"], "date": "2021-01-14T00:00:00Z", "doi": "10.1016/j.eclinm.2020.100715", "meta_date_publication": "2021 Feb", "meta_volume": "32", "meta_issue": "", "meta_pages": "100715", "score": 50263.496, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ did not reduce @<m>DISEASE_Angiomyolipoma</m> @DISEASE_MESH:D018207 @@@AML@@@ volume. ", "citations": {"NLM": "Amin S, Mallick AA, Edwards H, Cortina-Borja M, Laugharne M, Likeman M, O'Callaghan FJK. The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial EClinicalMedicine. 2021 Feb;32():100715. PMID: 33681737", "BibTeX": "@article{33681737, title={The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial}, author={Amin S and Mallick AA and Edwards H and Cortina-Borja M and Laugharne M and Likeman M and O'Callaghan FJK}, journal={EClinicalMedicine}, volume={32}, pages={100715}}"}}]}